Source: Clinical Ink Blog

Clinical Ink Blog Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer

Clinical ink announced the appointment of Dr. Nicholas Alp as Chief Medical Officer will lead the creation of innovative solutions and commercial strategies for clinical trial technology based on his experience as an interventional cardiologist and clinical trialist.The post Clinical ink Appoints Dr. Nicholas Alp, MD PhD as Chief Medical Officer appeared first on Clinical ink.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Jonathan Goldman's photo - CEO of Clinical Ink

CEO

Jonathan Goldman

CEO Approval Rating

62/100

Read more